These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 34964685)

  • 1. Responsiveness and Minimal Clinically Important Difference of the Chinese Version of the Motor Function Measure-32 in Children and Adolescents with Duchenne Muscular Dystrophy.
    Huang M; Chen T; Wang Y; Zhou C; Cao J; Lu X
    Dev Neurorehabil; 2022 Aug; 25(6):370-377. PubMed ID: 34964685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness and Minimal Clinically Important Difference of the Motor Function Measure in Collagen VI-Related Dystrophies and Laminin Alpha2-Related Muscular Dystrophy.
    Le Goff L; Meilleur KG; Norato G; Rippert P; Jain M; Fink M; Foley AR; Waite M; Donkervoort S; Bönnemann CG; Vuillerot C
    Arch Phys Med Rehabil; 2021 Apr; 102(4):604-610. PubMed ID: 33166523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroids in Duchenne muscular dystrophy: impact on the motor function measure sensitivity to change and implications for clinical trials.
    Schreiber A; Brochard S; Rippert P; Fontaine-Carbonnel S; Payan C; Poirot I; Hamroun D; Vuillerot C;
    Dev Med Child Neurol; 2018 Feb; 60(2):185-191. PubMed ID: 28990163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI Assessment of Motor Capabilities in Patients with Duchenne Muscular Dystrophy According to the Motor Function Measure Scale.
    Suslov V; Suslova G; Lytaev S
    Tomography; 2022 Apr; 8(2):948-960. PubMed ID: 35448710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining minimal clinically important differences in the North Star Ambulatory Assessment (NSAA) for patients with Duchenne muscular dystrophy.
    Ayyar Gupta V; Pitchforth JM; Domingos J; Ridout D; Iodice M; Rye C; Chesshyre M; Wolfe A; Selby V; Mayhew A; Mazzone ES; Ricotti V; Hogrel JY; Niks EH; de Groot I; Servais L; Straub V; Mercuri E; Manzur AY; Muntoni F;
    PLoS One; 2023; 18(4):e0283669. PubMed ID: 37099511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Minimal Clinical Important Difference (MCID) in Annual Rate of Change of Timed Function Tests in Boys with DMD.
    Duong T; Canbek J; Birkmeier M; Nelson L; Siener C; Fernandez-Fernandez A; Henricson E; McDonald CM; Gordish-Dressman H;
    J Neuromuscul Dis; 2021; 8(6):939-948. PubMed ID: 34151852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsiveness of the motor function measure in patients with spinal muscular atrophy.
    Vuillerot C; Payan C; Iwaz J; Ecochard R; Bérard C;
    Arch Phys Med Rehabil; 2013 Aug; 94(8):1555-61. PubMed ID: 23380348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor assessment in patients with Duchenne muscular dystrophy.
    Diniz GP; Lasmar LM; Giannetti JG
    Arq Neuropsiquiatr; 2012 Jun; 70(6):416-21. PubMed ID: 22699538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative muscle MRI: A powerful surrogate outcome measure in Duchenne muscular dystrophy.
    Bonati U; Hafner P; Schädelin S; Schmid M; Naduvilekoot Devasia A; Schroeder J; Zuesli S; Pohlman U; Neuhaus C; Klein A; Sinnreich M; Haas T; Gloor M; Bieri O; Fischmann A; Fischer D
    Neuromuscul Disord; 2015 Sep; 25(9):679-85. PubMed ID: 26096788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability and validity of the Thai version of the Pediatric Quality of Life inventory™ 3.0 Duchenne Muscular Dystrophy module in Thai children with Duchenne Muscular Dystrophy.
    Thongsing A; Likasitwattanakul S; Sanmaneechai O
    Health Qual Life Outcomes; 2019 May; 17(1):76. PubMed ID: 31046775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory Duchenne muscular dystrophy children: cross-sectional correlation between function, quantitative muscle ultrasound and MRI.
    Abdulhady H; Sakr HM; Elsayed NS; El-Sobky TA; Fahmy N; Saadawy AM; Elsedfy H
    Acta Myol; 2022 Mar; 41(1):1-14. PubMed ID: 35465338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial.
    Hafner P; Bonati U; Rubino D; Gocheva V; Zumbrunn T; Gueven N; Fischer D
    Trials; 2016 Aug; 17(1):389. PubMed ID: 27488051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness of the motor function measure in neuromuscular diseases.
    Vuillerot C; Payan C; Girardot F; Fermanian J; Iwaz J; Bérard C; Ecochard R;
    Arch Phys Med Rehabil; 2012 Dec; 93(12):2251-6.e1. PubMed ID: 22705238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor function measure scale, steroid therapy and patients with Duchenne muscular dystrophy.
    Silva EC; Machado DL; Resende MB; Silva RF; Zanoteli E; Reed UC
    Arq Neuropsiquiatr; 2012 Mar; 70(3):191-5. PubMed ID: 22392111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responsiveness of the Gait Domain of the Functional Evaluation Scale for Children with Duchenne Muscular Dystrophy.
    de Carvalho EV; Caromano FA; Goya PSA; Hukuda ME; Voos MC
    Phys Occup Ther Pediatr; 2019; 39(1):107-118. PubMed ID: 29851524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of motor and respiratory function in Duchenne muscular dystrophy patients.
    Luiz LC; Marson FAL; Bresciani Almeida CC; Toro AADC; Nucci A; Ribeiro JD
    Respir Physiol Neurobiol; 2019 Apr; 262():1-11. PubMed ID: 30660861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rasch analysis of the 32-item motor function measure in ambulant patients with Duchenne muscular dystrophy.
    Huang M; Chen T; Zhou C; Wang Y; Zeng H; Lu X; Cao J
    Clin Rehabil; 2023 Apr; 37(4):569-582. PubMed ID: 36285505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor function measure: validation of a short form for young children with neuromuscular diseases.
    de Lattre C; Payan C; Vuillerot C; Rippert P; de Castro D; Bérard C; Poirot I;
    Arch Phys Med Rehabil; 2013 Nov; 94(11):2218-26. PubMed ID: 23602884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring changes and predicting loss of ambulation in Duchenne muscular dystrophy with the Motor Function Measure.
    Vuillerot C; Girardot F; Payan C; Fermanian J; Iwaz J; De Lattre C; Berard C
    Dev Med Child Neurol; 2010 Jan; 52(1):60-5. PubMed ID: 19453691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between muscle strength and motor function in Duchenne muscular dystrophy.
    Nunes MF; Hukuda ME; Favero FM; Oliveira AB; Voos MC; Caromano FA
    Arq Neuropsiquiatr; 2016 Jul; 74(7):530-5. PubMed ID: 27487372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.